
Explore the key conclusions around aiming for higher treatment targets, discussed at the UCB-sponsored Satellite Symposium presented at EULAR 2023.
Dr Oseme Etomi is an obstetric physician in London, UK, and works across three National Health System (NHS) trusts including Guy’s and St Thomas’, King’s and the Queen Elizabeth NHS hospital trusts.
Her background is in rheumatology and general medicine and her main field of interest is in obstetric rheumatology, looking after women with inflammatory rheumatic diseases (IRDs) in pregnancy.
Dr Etomi was trained in some of London’s most prestigious rheumatology centres, including the Royal Free Hospital (National Centre for Scleroderma and Other Connective Tissue Disorders) and Barts Health NHS Trust and the Royal London Hospital (National Centre of Inflammatory Arthritis and Systemic Lupus Erythematosus).
In 2017, Dr Etomi undertook a clinical fellowship at St Thomas’ Hospital, and she now runs a weekly Rheumatic Disease in Pregnancy clinic, seeing patients with the whole spectrum of IRDs.
Dr Etomi has published numerous abstracts and papers on IRDs and pregnancy. In 2018, she was awarded the best oral presentation at the International Society of Obstetric Medicine (ISOM) for her work in this field.
Dr Etomi was instrumental in setting up the British Society of Rheumatology (BSR) Special Interest Group in Pregnancy in 2019. She sits on the advisory board for the Biologics in Rheumatoid Arthritis in Pregnancy (BiRAP) group and is currently one of the organisers of the 12th Rheumapreg Symposium in September 2023 in London.
PsA and axSpA have overlapping disease manifestations which are driven by inflammation.1 Explore several extracellular cytokines that are implicated in these...
Watch Prof Frank Behrens discuss the importance of treating skin symptoms in addition to musculoskeletal symptoms for patients with SpA.
Achieving ACR50 is associated with improvements in quality of life for patients with PsA.1 Dive into the data supporting higher treatment targets in clinical...
Watch Prof Lars Erik Kristensen and Prof Frank Behrens discuss how MDA is a realistic treatment target in clinical practice and the barriers to achieving it for...
Treatment for PsA should target a broad range of musculoskeletal and extra-articular manifestations.1 Listen to Assoc. Prof Philipp Sewerin explain how MDA can...
Explore the key conclusions around aiming for higher treatment targets, discussed at the UCB-sponsored Satellite Symposium presented at EULAR 2023.